Publication list - Publika - Scientific publications from Oslo University Hospital

Publications by Mark M. Baekelandt

54 publications found

Original articles

Khouja MH, Baekelandt M, Sarab A, Nesland JM, Holm R (2010)
Limitations of tissue microarrays compared with whole tissue sections in survival analysis
Oncol Lett, 1 (5), 827-831
DOI 10.3892/ol_00000145, PubMed 22966388

Baekelandt MM, Castiglione M, ESMO Guidelines Working Group (2009)
Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol, 20 Suppl 4, 29-31
DOI 10.1093/annonc/mdp120, PubMed 19454455

Lhommé C, Joly F, Walker JL, Lissoni AA, Nicoletto MO, Manikhas GM, Baekelandt MM, Gordon AN, Fracasso PM, Mietlowski WL, Jones GJ, Dugan MH (2008)
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer
J Clin Oncol, 26 (16), 2674-82
DOI 10.1200/JCO.2007.14.9807, PubMed 18509179

Baekelandt MM, Castiglione M, ESMO Guidelines Working Group (2008)
Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up
Ann Oncol, 19 Suppl 2, ii19-20
DOI 10.1093/annonc/mdn113, PubMed 18456753

Box I, Marrannes J, De Peuter B, Baekelandt M (2008)
Large mammographic opacity due to hamartoma
JBR-BTR, 91 (4), 177
PubMed 18817100

Davidson B, Baekelandt M, Shih IeM (2007)
MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells
Diagn Cytopathol, 35 (12), 756-60
DOI 10.1002/dc.20771, PubMed 18008338

Khouja MH, Baekelandt M, Nesland JM, Holm R (2007)
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
Int J Gynecol Pathol, 26 (4), 418-25
DOI 10.1097/pgp.0b013e31804216a0, PubMed 17885492

Gorovetz M, Baekelandt M, Berner A, Trope' CG, Davidson B, Reich R (2006)
The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma
Gynecol Oncol, 103 (3), 831-40
DOI 10.1016/j.ygyno.2006.06.042, PubMed 16919315

Wu Q, Suo Z, Kristensen GB, Baekelandt M, Nesland JM (2006)
The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma
Gynecol Oncol, 102 (1), 15-21
DOI 10.1016/j.ygyno.2005.11.034, PubMed 16499955

Van de Putte G, Lie AK, Vach W, Baekelandt M, Kristensen GB (2005)
Risk grouping in stage IB squamous cell cervical carcinoma
Gynecol Oncol, 99 (1), 106-12
DOI 10.1016/j.ygyno.2005.05.026, PubMed 16137752

Van de Putte G, Holm R, Lie AK, Baekelandt M, Kristensen GB (2005)
Markers of apoptosis in stage IB squamous cervical carcinoma
J Clin Pathol, 58 (6), 590-4
DOI 10.1136/jcp.2004.021220, PubMed 15917408

Gryspeerdt S, Lefere P, Herman M, Deman R, Rutgeerts L, Ghillebert G, Baert F, Baekelandt M, Van Holsbeeck B (2005)
CT colonography with fecal tagging after incomplete colonoscopy
Eur Radiol, 15 (6), 1192-202
DOI 10.1007/s00330-005-2644-x, PubMed 15702335

Marrannes J, Gryspeerdt S, Haspeslagh M, van Holsbeeck B, Baekelandt M, Lefere P (2005)
Fibrolamellar hepatocellular carcinoma in a 65-year-old woman: CT features
JBR-BTR, 88 (5), 237-40
PubMed 16302333

Van de Putte G, Kristensen GB, Baekelandt M, Lie AK, Holm R (2004)
E-cadherin and catenins in early squamous cervical carcinoma
Gynecol Oncol, 94 (2), 521-7
DOI 10.1016/j.ygyno.2004.05.046, PubMed 15297198

Wang Y, Kringen P, Kristensen GB, Holm R, Baekelandt MM, Olivier M, Skomedal H, Hainaut P, Tropé CG, Abeler VM, Nesland JM, Børresen-Dale AL, Helland A (2004)
Effect of the codon 72 polymorphism (c.215G>C, p.Arg72Pro) in combination with somatic sequence variants in the TP53 gene on survival in patients with advanced ovarian carcinoma
Hum Mutat, 24 (1), 21-34
DOI 10.1002/humu.20055, PubMed 15221786

Van Mieghem IM, Gryspeerdt S, Baekelandt M, van Holsbeeck B, Lefere P, Haspeslagh M, Dalle I (2004)
Papillary serous adenocarcinoma of the endometrium: CT-pathologic correlation
AJR Am J Roentgenol, 182 (6), 1534-6
DOI 10.2214/ajr.182.6.1821534, PubMed 15150003

Davidson B, Goldberg I, Tell L, Vigdorchik S, Baekelandt M, Berner A, Kristensen GB, Reich R, Kopolovic J (2004)
The clinical role of the PEA3 transcription factor in ovarian and breast carcinoma in effusions
Clin Exp Metastasis, 21 (3), 191-9
DOI 10.1023/b:clin.0000037703.37275.35, PubMed 15387369

Van de Putte G, Kristensen GB, Lie AK, Baekelandt M, Holm R (2004)
Cyclins and proliferation markers in early squamous cervical carcinoma
Gynecol Oncol, 92 (1), 40-6
DOI 10.1016/j.ygyno.2003.10.022, PubMed 14751136

Baekelandt M (2003)
The potential role of neoadjuvant chemotherapy in advanced ovarian cancer
Int J Gynecol Cancer, 13 Suppl 2, 163-8
DOI 10.1111/j.1525-1438.2003.13354.x, PubMed 14656274

Gryspeerdt S, Lefere P, Dewyspelaere J, Baekelandt M, van Holsbeeck B (2002)
Optimisation of colon cleansing prior to computed tomographic colonography
JBR-BTR, 85 (6), 289-96
PubMed 12553658

Kaern J, Baekelandt M, Tropé CG (2002)
A phase II study of weekly paclitaxel in platinum and paclitaxel-resistant ovarian cancer patients
Eur J Gynaecol Oncol, 23 (5), 383-9
PubMed 12440808

Baekelandt M, Lehne G, Tropé CG, Szántó I, Pfeiffer P, Gustavssson B, Kristensen GB (2001)
Phase I/II trial of the multidrug-resistance modulator valspodar combined with cisplatin and doxorubicin in refractory ovarian cancer
J Clin Oncol, 19 (12), 2983-93
DOI 10.1200/JCO.2001.19.12.2983, PubMed 11408493

Baay MF, Tjalma WA, Weyler J, Pattyn GG, Lambrechts HA, Goovaerts G, Baekelandt M, Buytaert P, Van Marck EA, Lardon F, Vermorken JB (2001)
Prevalence of human papillomavirus in elderly women with cervical cancer
Gynecol Obstet Invest, 52 (4), 248-51
DOI 10.1159/000052984, PubMed 11729338

Baekelandt M, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer
J Clin Oncol, 18 (22), 3775-81
DOI 10.1200/JCO.2000.18.22.3775, PubMed 11078490

Baekelandt M, Jorunn Nesbakken A, Kristensen GB, Tropé CG, Abeler VM (2000)
Carcinoma of the fallopian tube
Cancer, 89 (10), 2076-84
PubMed 11066048

Mertens H, Van Holsbeeck B, Gryspeerdt S, Gellens P, Baekelandt M, Lefere P (2000)
Percutaneous treatment of acute multiple limb ischemia
JBR-BTR, 83 (5), 238-42
PubMed 11201538

Tropé CG, Abeler V, Baekelandt M, Kaern J (2000)
[DNA ploidy in epithelial ovarian cancer--an independent prognostic factor]
Tidsskr Nor Laegeforen, 120 (1), 43-9
PubMed 10815478

Baekelandt MM, Holm R, Nesland JM, Tropé CG, Kristensen GB (2000)
P-glycoprotein expression is a marker for chemotherapy resistance and prognosis in advanced ovarian cancer
Anticancer Res, 20 (2B), 1061-7
PubMed 10810398

Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
The significance of metastasis-related factors cathepsin-D and nm23 in advanced ovarian cancer
Ann Oncol, 10 (11), 1335-41
DOI 10.1023/a:1008352502465, PubMed 10631462

Baekelandt M, Holm R, Tropé CG, Nesland JM, Kristensen GB (1999)
Lack of independent prognostic significance of p21 and p27 expression in advanced ovarian cancer: an immunohistochemical study
Clin Cancer Res, 5 (10), 2848-53
PubMed 10537352

Baekelandt M, Kristensen GB, Nesland JM, Tropé CG, Holm R (1999)
Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer
J Clin Oncol, 17 (7), 2061
DOI 10.1200/JCO.1999.17.7.2061, PubMed 10561259

Lefere P, Gryspeerdt S, Van Holsbeeck B, Baekelandt M (1999)
Diagnosis and treatment of expanding haematoma of the lateral abdominal wall after blunt abdominal trauma
Eur Radiol, 9 (8), 1553-5
DOI 10.1007/s003300050883, PubMed 10525864

Baekelandt M, Kristensen GB, Tropé CG, Nesland JM, Holm R (1999)
Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer
Anticancer Res, 19 (5C), 4469-74
PubMed 10650794

Desrumaux I, Baekelandt M, Verbeke W, Gryspeerdt S, Van Holsbeeck B, Lefere P (1998)
Localized benign fibrous mesothelioma mimicking a malignant tumor of the pleura
JBR-BTR, 81 (3), 131-3
PubMed 10547262

Kristensen GB, Baekelandt M, Vergote IB, Tropé C (1995)
A phase II study of carboplatin and hexamethylmelamine as induction chemotherapy in advanced epithelial ovarian carcinoma
Eur J Cancer, 31A (11), 1778-80
DOI 10.1016/0959-8049(95)00274-m, PubMed 8541099

Makar AP, Baekelandt M, Tropé CG, Kristensen GB (1995)
The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer
Gynecol Oncol, 56 (2), 175-80
DOI 10.1006/gyno.1995.1027, PubMed 7896181

Baekelandt M, Rigauts H, Wilms G (1993)
Perisplenic pseudocyst
J Belge Radiol, 76 (6), 394
PubMed 8163437

Baekelandt M, Kockx M, Wesling F, Gerris J (1993)
Primary adenocarcinoma of the fallopian tube. Review of the literature
Int J Gynecol Cancer, 3 (2), 65-71
DOI 10.1046/j.1525-1438.1993.03020065.x, PubMed 11578324

Hellemans P, Verdonk P, Baekelandt M, Joostens M, Francx M, Gerris J (1992)
Preliminary results with the use of the ROM-check immunoassay in the early detection of rupture of the amniotic membranes
Eur J Obstet Gynecol Reprod Biol, 43 (3), 173-9
DOI 10.1016/0028-2243(92)90170-4, PubMed 1563568

Baekelandt M, D'Haenens P, Wynant H, Fonteyne E, Stockx L, Leyman P (1991)
Occult prostatic abscess detected by transrectal sonography and computed tomography. Case report
J Belge Radiol, 74 (3), 217-9
PubMed 1797788

Baekelandt M, Vander Spek P, Leyman P, Stockx L, Van Steenberge R, D'Haenens P, Rollier A (1991)
Common hepatic artery aneurysm: diagnosis with duplex sonography and color Doppler
J Belge Radiol, 74 (3), 209-11
PubMed 1797786

Baekelandt M, Ponette E (1989)
Systemic scleroderma involving the GI tract
J Belge Radiol, 72 (6), 502-3
PubMed 2621202

Van Dam PA, Renier M, Baekelandt M, Buytaert P, Uyttenbroeck F (1989)
Disseminated intravascular coagulation and the syndrome of hemolysis, elevated liver enzymes, and low platelets in severe preeclampsia
Obstet Gynecol, 73 (1), 97-102
PubMed 2909047

Geerinckx KR, Baekelandt M, Dauwe D, Pandelaere I (1987)
An advanced abdominal twin gestation after primary infertility and after tubal pregnancy
Eur J Obstet Gynecol Reprod Biol, 26 (3), 283-8
DOI 10.1016/0028-2243(87)90082-7, PubMed 3123288

Review articles

Mebis J, De Raeve H, Baekelandt M, Tjalma WA, Vermorken JB (2004)
Primary ovarian small cell carcinoma of the pulmonary type: a case report and review of the literature
Eur J Gynaecol Oncol, 25 (2), 239-41
PubMed 15032292

Baekelandt M (2002)
Irofulven (MGI Pharma)
Curr Opin Investig Drugs, 3 (10), 1517-26
PubMed 12431030

Baekelandt M (2002)
Hormonal treatment of endometrial carcinoma
Expert Rev Anticancer Ther, 2 (1), 106-12
DOI 10.1586/14737140.2.1.106, PubMed 12113059

Tropé CG, Baekelandt M, Bjørge T, Abeler V, Kaern J (2000)
[Borderline tumors of the ovary]
Tidsskr Nor Laegeforen, 120 (23), 2764-70
PubMed 11107921

Tropé C, Paulsen T, Baekelandt M, Makar A (2000)
[Controversies in surgical treatment of advanced ovarian cancer]
Tidsskr Nor Laegeforen, 120 (7), 824-30
PubMed 10806907

Lehne G, Elonen E, Baekelandt M, Skovsgaard T, Peterson C (1998)
Challenging drug resistance in cancer therapy--review of the First Nordic Conference on Chemoresistance in Cancer Treatment, October 9th and 10th, 1997
Acta Oncol, 37 (5), 431-9
DOI 10.1080/028418698430377, PubMed 9831371

Baekelandt M, Leyman P, Wynant H, Stockx L, Van Steenberge R, D'Haenens P (1991)
Spontaneous retroperitoneal renal hemorrhage: imaging and angiographic findings in five patients
J Belge Radiol, 74 (3), 213-6
PubMed 1797787

Baekelandt M, Vansteenberge R, Van der Spek P, D'Haenens P, Rollier A, Stockx L (1990)
Rectal stenosis following the use of suppositories containing paracetamol and acetylsalicylic acid
Gastrointest Radiol, 15 (2), 171-3
DOI 10.1007/BF01888766, PubMed 2180779